
Weekly reports on the good, the bad, and the ugly of US healthcare.
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 39 | Subscribers | Read | jeffgoldberg.substack.com |
Curious about how many subscribers Jeff Goldberg’s Notes from a Pharma Bro has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over six million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Recent posts by this newsletter. Browse the email archive.
Last week, The New York Times Magazine ran a cover story titled The End of Baldness with a graphic of a guy whose thick mound of hair resembled Henry Spencer’s in the film Eraserhead. Finasteride, the miracle hair-growing remedy featured in...
A couple of months ago I dreamt of a smell. I woke up and the smell lingered in my nostrils; I fell back asleep and dreamed the smell again. It was a funky, sweet smell, like rotting flowers or the soggy food scraps we save for compost; a “...
In 2015, the original pharma bro Martin Shkreli, as the young CEO of Turing Pharmaceuticals, bought the marketing rights to a life-saving antifungal drug for people with HIV/AIDS and promptly raised the price from $13.50 to $750 a pill—an i...
Last Friday, March 13th, the New York Times carried a story titled Bad News for Friggatriskaidekaphobes, observing that because 2026 has three Fridays the 13th it might be a bad year for people with friggatriskaidekaphobia. Such folks have ...
Other publications recommended by the authors of this newsletter.
The writers behind this newsletter.
Science and medical writer. Author of Flowers in the Blood, a history of opium, and Anatomy of a Scientific Discovery, an on the scene account of the race to discover endorphins.
You can find recent issues that have been published by Jeff Goldberg’s Notes from a Pharma Bro on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Jeff Goldberg’s Notes from a Pharma Bro, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Jeff Goldberg’s Notes from a Pharma Bro as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Jeff Goldberg’s Notes from a Pharma Bro using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Similar Newsletters to see other publications like Jeff Goldberg’s Notes from a Pharma Bro. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.